DNMT1 and cancer: More recent studies have begun to recognize curcumin’s effect in modulating epigenetic processes in cancer cells, in which curcumin has been shown to be a histone acetyltransferase (HAT) inhibitor [30], [31], as well as a potential DNMT1 inhibitor, which results in hypomethylation of various genes including RARβ2 in cervical cancer cells [32]–[34].